% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • joelord57 Apr 23, 2013 3:20 PM Flag

    Amarantus Appoints Russell Miller as Director of Investor Relations

    SUNNYVALE, Calif.-- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a
    biotechnology company discovering and developing treatments and diagnostics for
    diseases associated with the neurodegeneration and apoptosis, today announced it has
    appointed Russell Miller as Director of Investor Relations.
    Mr. Miller previously served as Director of Investor Relations for US Data Works and for
    Force Protection, Inc. He has assisted in raising capital for companies both public and
    private, including real estate financing, development, and joint ventures for over 20 years.
    He has successfully participated in private placements, mezzanine financing, joint
    ventures, mergers and acquisitions, reverse mergers, national exchange up-listings and
    acquisitions for companies on the OTC, AMEX, and NASDAQ. As a consultant Mr. Miller
    has assisted a multitude of companies by developing their strategic plans for growth,
    liquidity, and return on equity by facilitating relationships with investment bankers,
    government relations officers, financiers, the media, and marketing and public relation
    firms. He has a broad range of worldwide contacts throughout the investment banking
    community, which include a large number of accredited investors and investment

    Sentiment: Hold

0.0562-0.0033(-5.55%)Mar 27 3:59 PMEDT